Frequency-domain photoacoustic microscopy with resonant transducer and interferometric modulation for high-reliability sO2 imaging
Frequency-domain photoacoustic microscopy (FD-PAM) could leverage a high-Q resonant ultrasound transducer to suppress out-of-band noise and lower the noise-equivalent pressure (NEP) for truly simultaneous multi-wavelength functional imaging. In practice, however, conventional continuous-wave direct modulation makes it difficult to stay within the narrow resonance, leading most implementations to rely on low-Q broadband detectors instead. To obtain accurate and stable hemoglobin oxygen saturation (sO₂) measurements, we implement an acousto-optic modulator (AOM)-based interferometric modulation scheme in FD-PAM, enabling the practical use of a high-Q resonant ultrasound transducer while preserving truly simultaneous dual-wavelength excitation. FD-PAM with interferometric modulation operates robustly within the narrow bandwidth of the high-Q transducer and supports clean spectral separation (SSIM = 0.97 between frequency-separated channels), as well as quantitative sO₂ estimation with < 2% within-group variation across oxygenated, mixed, and deoxygenated conditions. We anticipate that this approach will be useful for monitoring drug-induced changes in hemoglobin oxygen saturation and quantitatively evaluating therapeutic response.
Authors
- Tae Joong Eom (ORCID: https://orcid.org/0000-0003-0556-4027)
- Yong-Jae Lee (ORCID: https://orcid.org/0000-0003-0460-156X)
- Lihong V. Wang (ORCID: https://orcid.org/0000-0001-9783-4383)
Institutions
- California Institute of Technology (US)
- Pusan National University (KR)
Publication Details
- Journal
- Photoacoustics
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1016/j.pacs.2026.100834
- Primary Topic
- Photoacoustic and Ultrasonic Imaging
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Silicon Valley Community Foundation
- Korea Institute for Advancement of Technology
- National Research Foundation of Korea
- Ministry of SMEs and Startups
- National Institutes of Health